183 related articles for article (PubMed ID: 9714699)
1. Intranasal administration of HIV-DNA vaccine formulated with a polymer, carboxymethylcellulose, augments mucosal antibody production and cell-mediated immune response.
Hamajima K; Sasaki S; Fukushima J; Kaneko T; Xin KQ; Kudoh I; Okuda K
Clin Immunol Immunopathol; 1998 Aug; 88(2):205-10. PubMed ID: 9714699
[TBL] [Abstract][Full Text] [Related]
2. Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses.
Sun X; Zhang H; Xu S; Shi L; Dong J; Gao D; Chen Y; Feng H
Virol J; 2017 Aug; 14(1):163. PubMed ID: 28830557
[TBL] [Abstract][Full Text] [Related]
3. Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes.
Sasaki S; Sumino K; Hamajima K; Fukushima J; Ishii N; Kawamoto S; Mohri H; Kensil CR; Okuda K
J Virol; 1998 Jun; 72(6):4931-9. PubMed ID: 9573261
[TBL] [Abstract][Full Text] [Related]
4. Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.
Gherardi MM; Pérez-Jiménez E; Nájera JL; Esteban M
J Immunol; 2004 May; 172(10):6209-20. PubMed ID: 15128809
[TBL] [Abstract][Full Text] [Related]
5. Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1.
Lu Y; Xin KQ; Hamajima K; Tsuji T; Aoki I; Yang J; Sasaki S; Fukushima J; Yoshimura T; Toda S; Okada E; Okuda K
Clin Exp Immunol; 1999 Feb; 115(2):335-41. PubMed ID: 9933462
[TBL] [Abstract][Full Text] [Related]
6. Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations.
Cristillo AD; Ferrari MG; Hudacik L; Lewis B; Galmin L; Bowen B; Thompson D; Petrovsky N; Markham P; Pal R
J Gen Virol; 2011 Jan; 92(Pt 1):128-40. PubMed ID: 21169215
[TBL] [Abstract][Full Text] [Related]
7. [Intranasal priming with HIV DNA vaccine and systemic boosting with recombinant vaccinia induce vigorous immune responses: experiment with mice].
Huang XG; Xu JQ; Ren L; Qiu C; Zhang N; Liu LX; Wan YM; Peng H; Shao YM
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3109-13. PubMed ID: 17313761
[TBL] [Abstract][Full Text] [Related]
8. Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model.
Otero M; Calarota SA; Felber B; Laddy D; Pavlakis G; Boyer JD; Weiner DB
Vaccine; 2004 Apr; 22(13-14):1782-90. PubMed ID: 15068862
[TBL] [Abstract][Full Text] [Related]
9. IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine.
Xin KQ; Hamajima K; Sasaki S; Tsuji T; Watabe S; Okada E; Okuda K
Vaccine; 1999 Feb; 17(7-8):858-66. PubMed ID: 10067692
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens.
Okada E; Sasaki S; Ishii N; Aoki I; Yasuda T; Nishioka K; Fukushima J; Miyazaki J; Wahren B; Okuda K
J Immunol; 1997 Oct; 159(7):3638-47. PubMed ID: 9317164
[TBL] [Abstract][Full Text] [Related]
11. Improvement in T helper 1-related immune responses in BALB/c mice immunized with an HIV-1 gag plasmid combined with a chimeric plasmid encoding interleukin-18 and flagellin.
Chen YL; Chen YS; Hung YC; Liu PJ; Tasi HY; Ni WF; Hseuh PT; Lin HH
Microbiol Immunol; 2015 Aug; 59(8):483-94. PubMed ID: 26094825
[TBL] [Abstract][Full Text] [Related]
12. Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1.
Sasaki S; Tsuji T; Hamajima K; Fukushima J; Ishii N; Kaneko T; Xin KQ; Mohri H; Aoki I; Okubo T; Nishioka K; Okuda K
Infect Immun; 1997 Sep; 65(9):3520-8. PubMed ID: 9284115
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant vaccine.
Sasaki S; Hamajima K; Fukushima J; Ihata A; Ishii N; Gorai I; Hirahara F; Mohri H; Okuda K
Infect Immun; 1998 Feb; 66(2):823-6. PubMed ID: 9453648
[TBL] [Abstract][Full Text] [Related]
14. Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant.
Borsutzky S; Fiorelli V; Ebensen T; Tripiciano A; Rharbaoui F; Scoglio A; Link C; Nappi F; Morr M; Buttó S; Cafaro A; Mühlradt PF; Ensoli B; Guzmán CA
Eur J Immunol; 2003 Jun; 33(6):1548-56. PubMed ID: 12778472
[TBL] [Abstract][Full Text] [Related]
15. Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1-specific immunity.
Xin KQ; Lu Y; Hamajima K; Fukushima J; Yang J; Inamura K; Okuda K
Clin Immunol; 1999 Jul; 92(1):90-6. PubMed ID: 10413656
[TBL] [Abstract][Full Text] [Related]
16. A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques.
Egan MA; Chong SY; Hagen M; Megati S; Schadeck EB; Piacente P; Ma BJ; Montefiori DC; Haynes BF; Israel ZR; Eldridge JH; Staats HF
Vaccine; 2004 Sep; 22(27-28):3774-88. PubMed ID: 15315859
[TBL] [Abstract][Full Text] [Related]
17. Immune responses against a new HIV-1 p24-gp41/pCAGGS-IL-12 DNA vaccine in Balb/c mice.
Roodbari F; Sabahi F; Sarbolouki MN; Barkhordari F; Adeli A; Jamedar A; Mahboudi F
Iran J Immunol; 2012 Jun; 9(2):86-97. PubMed ID: 22735796
[TBL] [Abstract][Full Text] [Related]
18. M cell DNA vaccination for CTL immunity to HIV.
Wang X; Hone DM; Haddad A; Shata MT; Pascual DW
J Immunol; 2003 Nov; 171(9):4717-25. PubMed ID: 14568947
[TBL] [Abstract][Full Text] [Related]
19. DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity.
Buonaguro L; Devito C; Tornesello ML; Schröder U; Wahren B; Hinkula J; Buonaguro FM
Vaccine; 2007 Aug; 25(32):5968-77. PubMed ID: 17629365
[TBL] [Abstract][Full Text] [Related]
20. Zymosan enhances the immune response to DNA vaccine for human immunodeficiency virus type-1 through the activation of complement system.
Ara Y; Saito T; Takagi T; Hagiwara E; Miyagi Y; Sugiyama M; Kawamoto S; Ishii N; Yoshida T; Hanashi D; Koshino T; Okada H; Okuda K
Immunology; 2001 May; 103(1):98-105. PubMed ID: 11380697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
